Cargando…

Autonomic dysregulation and phenobarbital in patients with masked primary hypertension

INTRODUCTION: Primary hypertension can be masked and be responsible of a severe impact on the target bodies. The purpose of this study was to see if Phenobarbital at low dose is able to decrease the sympathetic hyperactivity assessed by cardiovascular autonomic reflexes in patients with masked hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakkali, Mustapha EL., Aboudrar, Souad, Dakka, Taoufiq, Benjelloun, Halima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002820/
https://www.ncbi.nlm.nih.gov/pubmed/32042972
http://dx.doi.org/10.1016/j.heliyon.2020.e03239
_version_ 1783494429079764992
author Bakkali, Mustapha EL.
Aboudrar, Souad
Dakka, Taoufiq
Benjelloun, Halima
author_facet Bakkali, Mustapha EL.
Aboudrar, Souad
Dakka, Taoufiq
Benjelloun, Halima
author_sort Bakkali, Mustapha EL.
collection PubMed
description INTRODUCTION: Primary hypertension can be masked and be responsible of a severe impact on the target bodies. The purpose of this study was to see if Phenobarbital at low dose is able to decrease the sympathetic hyperactivity assessed by cardiovascular autonomic reflexes in patients with masked hypertension. MATERIALS AND METHODS: This prospective study was conducted on a total of 91 patients with masked hypertension (average age 52.1 ± 10.3 years old). The cardiovascular autonomic tests performed in this group, before and after 3 months of daily oral administration of Phenobarbital, included deep breathing, hand-grip, mental stress and orthostatic tests. Statistical analysis was done using the Student's t-test, Univariate and Multivariate logistic regression analysis; p is significant if < 0.05. RESULTS: Cardiovascular autonomic reflexes responses before and after 3 months of Phenobarbital oral administration were as follows: Vagal response (XDB) obtained on deep breathing test was of 32.6 ± 5.4% VS 30.4 ± 6.1%, (p = 0.08), alpha peripheral sympathetic response (alpha SP) obtained on hand grip test was of 35.6 ± 8.7% VS 12.0 ± 2.5%, (p < 0.001), alpha central sympathetic response (alpha SC), beta central sympathetic response (beta SC) obtained during mental stress were of respectively 29.3 ± 9.2% VS 11.8 ± 2.4%, (p < 0.001) and 11.0 ± 5.3% VS 10.4 ± 6.1%, (p = 0.2), alpha peripheral adrenergic sympathetic (alpha PAS) obtained during orthostatic test was of 25.3 ± 6.0% VS 13.0 ± 3.4%, (p < 0.001). CONCLUSION: These results demonstrated that Phenobarbital at low dose may have an anti-sympathetic effect in patients with masked hypertension.
format Online
Article
Text
id pubmed-7002820
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70028202020-02-10 Autonomic dysregulation and phenobarbital in patients with masked primary hypertension Bakkali, Mustapha EL. Aboudrar, Souad Dakka, Taoufiq Benjelloun, Halima Heliyon Article INTRODUCTION: Primary hypertension can be masked and be responsible of a severe impact on the target bodies. The purpose of this study was to see if Phenobarbital at low dose is able to decrease the sympathetic hyperactivity assessed by cardiovascular autonomic reflexes in patients with masked hypertension. MATERIALS AND METHODS: This prospective study was conducted on a total of 91 patients with masked hypertension (average age 52.1 ± 10.3 years old). The cardiovascular autonomic tests performed in this group, before and after 3 months of daily oral administration of Phenobarbital, included deep breathing, hand-grip, mental stress and orthostatic tests. Statistical analysis was done using the Student's t-test, Univariate and Multivariate logistic regression analysis; p is significant if < 0.05. RESULTS: Cardiovascular autonomic reflexes responses before and after 3 months of Phenobarbital oral administration were as follows: Vagal response (XDB) obtained on deep breathing test was of 32.6 ± 5.4% VS 30.4 ± 6.1%, (p = 0.08), alpha peripheral sympathetic response (alpha SP) obtained on hand grip test was of 35.6 ± 8.7% VS 12.0 ± 2.5%, (p < 0.001), alpha central sympathetic response (alpha SC), beta central sympathetic response (beta SC) obtained during mental stress were of respectively 29.3 ± 9.2% VS 11.8 ± 2.4%, (p < 0.001) and 11.0 ± 5.3% VS 10.4 ± 6.1%, (p = 0.2), alpha peripheral adrenergic sympathetic (alpha PAS) obtained during orthostatic test was of 25.3 ± 6.0% VS 13.0 ± 3.4%, (p < 0.001). CONCLUSION: These results demonstrated that Phenobarbital at low dose may have an anti-sympathetic effect in patients with masked hypertension. Elsevier 2020-01-18 /pmc/articles/PMC7002820/ /pubmed/32042972 http://dx.doi.org/10.1016/j.heliyon.2020.e03239 Text en © 2020 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Bakkali, Mustapha EL.
Aboudrar, Souad
Dakka, Taoufiq
Benjelloun, Halima
Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title_full Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title_fullStr Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title_full_unstemmed Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title_short Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
title_sort autonomic dysregulation and phenobarbital in patients with masked primary hypertension
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002820/
https://www.ncbi.nlm.nih.gov/pubmed/32042972
http://dx.doi.org/10.1016/j.heliyon.2020.e03239
work_keys_str_mv AT bakkalimustaphael autonomicdysregulationandphenobarbitalinpatientswithmaskedprimaryhypertension
AT aboudrarsouad autonomicdysregulationandphenobarbitalinpatientswithmaskedprimaryhypertension
AT dakkataoufiq autonomicdysregulationandphenobarbitalinpatientswithmaskedprimaryhypertension
AT benjellounhalima autonomicdysregulationandphenobarbitalinpatientswithmaskedprimaryhypertension